查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1558350

2030 年血管閉合裝置市場預測：按產品、接取模式、應用、最終用戶和地區進行的全球分析

Vascular Closure Devices Market Forecasts to 2030 - Global Analysis By Product, Access Mode, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球血管閉合裝置市場規模為 13 億美元，預計在預測期內將以 8.3% 的複合年成長率成長，到 2030 年達到 21 億美元。血管閉合裝置 (VCD) 是一種用於密封或閉合血管穿孔的醫療裝置，通常在血管造影術或經皮冠狀動脈介入治療等導管手術後使用。這些裝置對於最大限度地減少出血、減少併發症以及透過加速穿刺部位的止血來加速恢復至關重要。 VCD 透過多種機制運行，包括機械壓縮、組織黏合劑以及專用塞子或補片的部署。 VCD透過有效阻斷血管入口，預防血腫、出血、感染疾病等併發症，讓患者更快恢復正常活動。

據英國心臟基金會稱，到 2024 年，全球將有約 6.2 億人患有心臟或循環系統疾病。根據醫療保險和醫療補助服務中心（CMS.gov）的資料，2023年，美國將在醫療保健方面支出約4.7兆美元，佔國民經濟的18%。

人們越來越偏好微創治療

人們對微創手術的日益偏好正在推動血管閉合裝置 (VCD) 的進步。 VCD 對於基於導管的干涉後有效閉合通路部位至關重要。隨著醫療保健轉向微創手術以加快患者康復時間並最大限度地減少併發症，VCD 正在不斷發展以滿足這些需求。現代 VCD 透過使用先進的材料和技術來確保快速、安全地閉合血管網路基地台，從而提高安全性、有效性和患者舒適度。這一趨勢反映了醫學領域更廣泛的趨勢，即採用更小切口、更少疼痛和更快恢復正常活動的手術。

臨床風險和併發症

血管閉合裝置 (VCD) 旨在在基於導管的手術後閉合股動脈通路部位，目的是最大限度地減少出血並加速康復。 VCD 的使用與臨床風險和併發症相關，阻礙了其有效性。主要風險包括感染、血腫形成、血管損傷，可導致肢體缺血、血栓症等併發症。也可能存在與設備相關的問題，例如密封不充分或設備移位，這可能導致出血或動脈損傷。

心血管手術增加

隨著血管成形術和支架置入術等手術的增加，對高效、安全和有效的 VCD 的需求正在迅速增加。現代VCD旨在快速止血，減少出血和感染等併發症，縮短復原時間。 VCD 技術的創新包括改進材料以實現更好的組織密封、提高臨床醫生的易用性以及適應各種血管通路部位的設計。這些進步不僅加快了患者的康復速度，還提高了手術效率，並解決了介入心臟病學增加的複雜性和頻率。

智慧財產權挑戰

由於智慧財產權（IP）問題，血管閉合裝置（VCD）產業面臨重大挑戰。專利糾紛和限制性智慧財產權主張可能會阻止新參與企業開發和銷售自己的設備，從而阻礙創新。現有公司通常持有涵蓋基礎技術的廣泛專利，為新興企業和其他競爭對手設置了障礙。這種情況可能會導致昂貴的法律訴訟並轉移研發資源。嚴格的智慧財產權法規可能會減緩新的、可能更好的設備進入市場的速度，並限制患者照護的進步。結果，市場受到限制，創新放緩，醫療設備成本居高不下，影響了患者的取得和治療選擇。

COVID-19 的影響：

由於選擇性手術的中斷和醫療保健優先事項的變化，COVID-19 大流行對血管閉合裝置 (VCD) 市場產生了重大影響。由於世界各地的醫院都專注於治療新冠肺炎 (COVID-19)嚴重病例，許多非緊急手術，包括需要血管通路的手術，被推遲或取消。這暫時減少了對 VCD 的需求，VCD 用於在導管手術後關閉動脈通路部位。供應鏈中斷和限制影響了這些儀器的生產和分銷。這次疫情也加速了遠端和微創診斷技術的採用，進一步影響了 VCD 的傳統使用。

預計主動逼近器部分在預測期內將達到最大

預計主動逼近器領域在預測期內將是最大的。主動接近器顯著提高了血管閉合裝置的有效性和易用性，從而徹底改變了血管閉合裝置。這些先進的設備利用動態機制來確保導管插入後留下的穿刺部位閉合。與依賴靜壓或手動操作的傳統被動方法不同，主動逼近器施加受控且可調節的力來精確對準和密封血管開口。這項創新可以實現可靠的閉合，同時最大限度地減少出血和感染等併發症。

預計腦血管介入領域在預測期內複合年成長率最高

預計腦血管介入領域在預測期內複合年成長率最高。腦血管介入領域的重點是提高血管閉合的準確性、降低併發症發生率、縮短恢復時間。現代 VCD 具有創新功能，例如改進的止血劑和適應性閉合機制，以改善進入部位的密封性並最大限度地減少對周圍組織的創傷。此外，結合即時影像和先進的追蹤系統可以實現更精確的設備放置和監控。

比最大的地區

由於最尖端科技的整合、醫療培訓的改善、監管流程的簡化等，歐洲地區在預測期內佔據最大的市場佔有率。先進的 VCD 對於導管插入術等手術後密封動脈穿刺至關重要，該全部區域醫療保健設施和研究的投資正在增加。增強的基礎設施正在促進全部區域創新設備的開發和部署，從而提供更高的準確性、安全性和患者舒適度。配備最先進工具和設備的醫院和診所將能夠更有效地利用這些先進的 VCD，從而改善手術結果並縮短恢復時間。這些因素正在推動區域成長。

複合年成長率最高的地區：

由於採用血管閉合裝置（VCD）並確保嚴格的安全性和有效性標準，預計歐洲地區在預測期內將顯著成長。歐盟的法規結構，包括醫療設備法規 (MDR) 和體外診斷法規 (IVDR)，要求對這些設備進行嚴格的臨床評估、品管措施和上市後監督。這種監管監督透過要求製造商遵守高標準、推動技術進步和改善整個全部區域的患者治療結果來促進創新。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球血管閉合裝置市場：依產品

  • 被動逼近器
  • 主動逼近器
  • 外部止血裝置

第6章全球血管閉合裝置市場：依接取模式分類

  • 股骨通路
  • 徑向訪問

第7章全球血管閉合裝置市場：依應用分類

  • 周邊血管介入治療
  • 腦血管介入
  • 其他用途

第8章全球血管閉合裝置市場：依最終用戶分類

  • 醫院
  • 心導管實驗室
  • 其他最終用戶

第9章全球血管閉合裝置市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、合作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章 公司概況

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cardinal Health, Inc
  • Endologix, Inc
  • GE Healthcare
  • HeartWare International, Inc
  • Medtronic PLC
  • Nipro Corporation
  • Stryker Corporation
  • Terumo Corporation
Product Code: SMRC27224

According to Stratistics MRC, the Global Vascular Closure Devices Market is accounted for $1.3 billion in 2024 and is expected to reach $2.1 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Vascular closure devices (VCDs) are medical instruments designed to seal or close punctures in blood vessels, typically following catheter-based procedures like angiography or percutaneous coronary interventions. These devices are crucial for minimizing bleeding, reducing complications, and expediting recovery by facilitating faster hemostasis at the puncture site. VCDs operate through various mechanisms, including mechanical compression, tissue adhesives, or the deployment of specialized plugs or patches. By effectively sealing the vascular entry point, VCDs help prevent complications such as hematomas, bleeding, or infections, and allow patients to resume normal activities more quickly.

According to the British Heart Foundation, in 2024, there are around 620 million people living with heart and circulatory diseases across the world. According to the data by Centers for Medicare and Medicaid Services (CMS.gov) shows that in 2023, the U.S. spent approximately USD 4.7 trillion on healthcare, constituting 18% of the national economy.

Market Dynamics:

Driver:

Growing preference for minimally invasive procedures

The increasing preference for minimally invasive procedures is driving advancements in Vascular Closure Devices (VCDs), which are crucial for efficiently closing access sites after catheter-based interventions. As healthcare shifts towards less invasive techniques to reduce patient recovery times and minimize complications, VCDs are evolving to meet these demands. Modern VCDs offer improved safety, efficacy, and patient comfort by using advanced materials and technologies to ensure rapid and secure closure of vascular access points. This trend reflects a broader movement in medicine towards procedures that involve smaller incisions, less pain, and quicker returns to normal activities.

Restraint:

Clinical risks and complications

Vascular Closure Devices (VCDs) are designed to close femoral artery access sites after catheter-based procedures, aiming to minimize bleeding and expedite recovery. Their use carries clinical risks and complications that can impede their effectiveness. Key risks include infection, hematoma formation, and vascular injury, which can lead to complications like limb ischemia or thrombosis. There is also the potential for device-related issues such as inadequate sealing or device migration, which can cause bleeding or arterial damage.

Opportunity:

Rise in cardiovascular procedures

As the volume of procedures like angioplasty and stent placements rises, the demand for efficient, safe, and effective VCDs has surged. Modern VCDs are designed to provide faster hemostasis, reduce complications such as bleeding and infection, and shorten recovery times. Innovations in VCD technology include improved materials for better tissue sealing, enhanced ease of use for clinicians, and designs that accommodate various vascular access sites. These advancements not only facilitate quicker patient recovery but also enhance procedural efficiency, aligning with the growing complexity and frequency of cardiovascular interventions.

Threat:

Intellectual property challenges

The vascular closure device (VCD) industry faces significant challenges due to intellectual property (IP) issues. Patent disputes and restrictive IP claims can stifle innovation by preventing new entrants from developing or marketing their own devices. Established companies often hold broad patents that cover fundamental technologies, creating barriers for startups and other competitors. This situation can lead to expensive legal battles, which divert resources away from research and development. Stringent IP regulations can delay the introduction of new, potentially better devices to the market, limiting advancements in patient care. The result is a constrained market where innovation is slowed, and the cost of devices may remain high, impacting accessibility and treatment options for patients.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the vascular closure devices (VCDs) market due to disruptions in elective procedures and a shift in healthcare priorities. As hospitals worldwide focused on managing severe COVID-19 cases, many non-urgent procedures, including those requiring vascular access, were postponed or canceled. This led to a temporary decline in demand for VCDs, which are used to close the arterial access site after catheter-based procedures. Supply chain disruptions and restrictions affected the production and distribution of these devices. The pandemic also accelerated the adoption of remote and less invasive diagnostic techniques, further impacting the traditional usage of VCDs.

The Active Approximators segment is expected to be the largest during the forecast period

Active Approximators segment is expected to be the largest during the forecast period. Active approximators are revolutionizing vascular closure devices by significantly improving their efficacy and ease of use. These advanced devices utilize dynamic mechanisms to securely close the puncture site left after catheterization procedures. Unlike traditional passive methods that rely on static pressure or manual manipulation, active approximators apply controlled, adjustable forces to precisely align and seal the vascular opening. This innovation enhances the device's ability to achieve a reliable closure with minimal complications, such as bleeding or infection.

The Cerebrovascular Interventions segment is expected to have the highest CAGR during the forecast period

Cerebrovascular Interventions segment is expected to have the highest CAGR during the forecast period. Cerebrovascular Interventions segment focus on increasing the precision of vascular closure, reducing complication rates, and shortening recovery times. Modern VCDs are designed with innovative features such as improved hemostatic agents and more adaptable closure mechanisms, which ensure better sealing of the access site and minimal trauma to surrounding tissues. Additionally, the incorporation of real-time imaging and advanced tracking systems allows for more accurate device placement and monitoring.

Region with largest share:

Europe region commanded the largest market share over the extrapolated period driven by the integration of cutting-edge technologies, improved medical training, and streamlined regulatory processes. Advanced VCDs, which are crucial for sealing arterial punctures after procedures like catheterizations, are benefiting from increased investment in healthcare facilities and research across the region. Enhanced infrastructure facilitates the development and deployment of innovative devices that offer greater precision, safety, and patient comfort throughout the region. Hospitals and clinics equipped with state-of-the-art tools and facilities can more effectively utilize these advanced VCDs, leading to improved procedural outcomes and reduced recovery times. These elements are boosting the regional growth.

Region with highest CAGR:

Europe region is projected to witness substantial growth during the forecast period due to the adoption of Vascular Closure Devices (VCDs) by ensuring stringent safety and efficacy standards. The European Union's regulatory framework, including the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), mandates rigorous clinical evaluations, quality control measures, and post-market surveillance for these devices. This regulatory oversight fosters innovation by encouraging manufacturers to adhere to high standards, thus driving advancements in technology and improving patient outcomes across the region.

Key players in the market

Some of the key players in Vascular Closure Devices market include Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc, Endologix, Inc, GE Healthcare, HeartWare International, Inc, Medtronic PLC, Nipro Corporation, Stryker Corporation and Terumo Corporation.

Key Developments:

In June 2024, Haemonetics Corporation has announced the launch of its new VASCADE MVP XL mid-bore venous closure device. The VASCADE MVP XL system adds to Haemonetics VASCADE line of vascular closure devices by using novel collapsible disc technology with a patented resorbable collagen patch that promotes fast hemostasis.

In November 2023, Johnson & Johnson Service Inc., a biotechnology company, announced the completion of the acquisition of Laminar, Inc., a privately held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).

In February 2023, the LockeT product was introduced to the market by Catheter Precision, Inc., a wholly-owned subsidiary of Ra Medical Systems, Inc. The first shipments of the product to its distributors will start right away. When a catheter is inserted through the skin into a blood artery and subsequently removed after an operation, LockeT can be utilized in combination with the closure of the percutaneous wound site.

Products Covered:

  • Passive Approximators
  • Active Approximators
  • External Haemostatic Devices

Access Modes Covered:

  • Femoral Access
  • Radial Access

Applications Covered:

  • Peripheral Vascular Interventions
  • Cerebrovascular Interventions
  • Other Applications

End Users Covered:

  • Hospitals
  • Cardiac Catheterization Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Vascular Closure Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Passive Approximators
  • 5.3 Active Approximators
  • 5.4 External Haemostatic Devices

6 Global Vascular Closure Devices Market, By Access Mode

  • 6.1 Introduction
  • 6.2 Femoral Access
  • 6.3 Radial Access

7 Global Vascular Closure Devices Market, By Application

  • 7.1 Introduction
  • 7.2 Peripheral Vascular Interventions
  • 7.3 Cerebrovascular Interventions
  • 7.4 Other Applications

8 Global Vascular Closure Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Cardiac Catheterization Laboratories
  • 8.4 Other End Users

9 Global Vascular Closure Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Laboratories
  • 11.2 Boston Scientific Corporation
  • 11.3 Cardinal Health, Inc
  • 11.4 Endologix, Inc
  • 11.5 GE Healthcare
  • 11.6 HeartWare International, Inc
  • 11.7 Medtronic PLC
  • 11.8 Nipro Corporation
  • 11.9 Stryker Corporation
  • 11.10 Terumo Corporation

List of Tables

  • Table 1 Global Vascular Closure Devices Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 4 Global Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 5 Global Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 6 Global Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 7 Global Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 8 Global Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 9 Global Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 10 Global Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 11 Global Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 12 Global Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 13 Global Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 14 Global Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 15 Global Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 16 Global Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 17 North America Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 18 North America Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 19 North America Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 20 North America Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 21 North America Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 22 North America Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 23 North America Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 24 North America Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 25 North America Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 North America Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 27 North America Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 28 North America Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 29 North America Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 30 North America Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 31 North America Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 32 North America Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 33 Europe Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 34 Europe Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 35 Europe Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 36 Europe Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 37 Europe Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 38 Europe Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 39 Europe Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 40 Europe Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 41 Europe Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 42 Europe Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 43 Europe Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 44 Europe Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 45 Europe Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 46 Europe Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 47 Europe Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 48 Europe Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 49 Asia Pacific Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 50 Asia Pacific Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 51 Asia Pacific Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 52 Asia Pacific Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 53 Asia Pacific Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 54 Asia Pacific Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 55 Asia Pacific Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 56 Asia Pacific Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 57 Asia Pacific Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 58 Asia Pacific Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 59 Asia Pacific Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 60 Asia Pacific Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 61 Asia Pacific Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 62 Asia Pacific Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 63 Asia Pacific Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 64 Asia Pacific Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 65 South America Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 66 South America Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 67 South America Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 68 South America Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 69 South America Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 70 South America Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 71 South America Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 72 South America Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 73 South America Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 74 South America Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 75 South America Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 76 South America Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 77 South America Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 78 South America Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 79 South America Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 80 South America Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 81 Middle East & Africa Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 82 Middle East & Africa Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 83 Middle East & Africa Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 84 Middle East & Africa Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 85 Middle East & Africa Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 86 Middle East & Africa Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 87 Middle East & Africa Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 88 Middle East & Africa Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 89 Middle East & Africa Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 90 Middle East & Africa Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 91 Middle East & Africa Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 92 Middle East & Africa Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 93 Middle East & Africa Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 94 Middle East & Africa Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 95 Middle East & Africa Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 96 Middle East & Africa Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)